The Role of Ankaferd Blood Stopper and Oxytocin as Potential Therapeutic Agents in Endometriosis: A Rat Model

Abstract

To evaluate the potential effect of Ankaferd Blood Stopper (ABS) and oxytocin (OT) in an experimental endometriosis model, 18 female Sprague Dawley rats were used in this study. The animals were divided randomly into three groups after surgical induction of endometriosis: group 1: control group (isotonic NaCl, 1 mL/kg/day, intramuscular, n=6); group 2: OT group (OT, 80 U/kg/day, intramuscular, n=6); group 3: ABS group (ABS, 1.5 mL/kg/day, intraperitoneal, n=6). Each group was treated for four weeks (two times per week). Volumes of endometriotic explants were measured in biopsy samples for histopathological analysis. Vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), and tumour necrosis factor (TNF-α) levels were measured in plasma and peritoneal fluid. Endometriotic explant volumes were significantly decreased after OT administration (P<0.0001). The epithelial score was significantly decreased in both treatment groups compared to the control group (P<0.05). TUNEL immunohistochemistry showed more apoptotic changes in the endometriosis foci (gland epithelium and surrounding tissue) in the OT group than in the control group (P<0.05). The levels of VEGF, MCP-1, and TNF-α were significantly reduced in the OT group (P<0.05), whereas no significant changes in protein levels were found in the ABS-applied group. The results indicate that OT has greater potential as a therapeutic agent in experimentally induced peritoneal endometriosis, where ABS, which is a VEGF modulator, appears to act through different mechanisms to show its palliative effects on a rat model of peritoneal endometriosis.

Keywords

endometriosis / Ankaferd Blood Stopper / oxytocin / cytokines

References

[1] BulunSE. Endometriosis. N Engl J Med, 2009, 360(3): 268-279

[2] SampsonJA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol, 1927, 14: 422-469

[3] BraunDP, DingJ, DmowskiWP. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertil Steril, 2002, 78(4): 727-732

[4] JiangQY, WuRJ. Growth mechanisms of endometriotic cells in implanted places: a review. Gynecol Endocrinol, 2012, 28(7): 562-567

[5] BourlevV, VolkovN, PavlovitchS, et al.. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction, 2006, 132(3): 501-509

[6] UlukusM, UlukusEC, Tavmergen GokerEN, et al.. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril, 2009, 91(3): 687-693

[7] MechsnerS, BartleyJ, LoddenkemperC, et al.. Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril, 2005, 83: 1220-1231

[8] SimsekY, CelikO, KaraerA, et al.. Therapeutic efficiency of Atosiban, an oxytocin receptor blocking agent in the treatment of experimental endometriosis. Arch Gynecol Obstet, 2012, 286(3): 777-783

[9] GokerH, HaznedarogluI, ErcetinS, et al.. Haemostatic Actions of the Folkloric Medicinal Plant Extract Ankaferd Blood Stopper. J Int Med Res, 2008, 36(1): 163-170

[10] LeeSJ, UmanoK, ShibamotoT, et al.. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem, 2005, 91(1): 131-137

[11] SimsekC, SelekS, KocaM, et al.. Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper. SAGE Open Med, 2017, 5: 2050312117722569

[12] SheelaML, RamakrishnaMK, SalimathBP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol, 2006, 6(3): 494-498

[13] VernonMW, WilsonEA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril, 1985, 44(5): 684-694

[14] GüneyM, OralB, KarahanN, et al.. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril, 2008, 89(4): 934-42

[15] PeterssonM, WibergU, LundebergT, et al.. Oxytocin decreases carrageenan induced inflammation in rats. Peptides, 2001, 22(9): 1479-1484

[16] CipilHS, KosarA, KayaA, et al.. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost, 2009, 15(3): 270-276

[17] KeenanJA, Williams-BoycePK, MasseyPJ, et al.. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril, 1999, 72(1): 135-141

[18] GiudiceLC, KaoLC. Endometriosis. Lancet, 2004, 364(9447): 1789-1799

[19] YoungVJ, AhmadSF, BrownJK, et al.. Peritoneal VEGF-A expression is regulated by TGF-β1 through an ID1 pathway in women with endometriosis. Sci Rep, 2015, 5: 16859

[20] GriffithJS, RodgersAK, SchenkenRS. Reviews: in vitro models to study the pathogenesis of endometriosis. Reprod Sci, 2010, 17(1): 5-12

[21] JiangL, YanY, LiuZ, et al.. Inflammation and endometriosis. Front Biosci (Landmark Ed.), 2016, 21: 941-948

[22] WeiJ, ZhaoB, ZhangC, et al.. Jiawei Foshou San Induces Apoptosis in Ectopic Endometrium Based on Systems Pharmacology, Molecular Docking, and Experimental Evidence. Evid Based Complement Alternat Med, 2019, 2019: 2360367

[23] DmowskiWP, DingJ, ShenJ, et al.. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod, 2001, 16(9): 1802-1808

[24] CelikO, AydinS, CelikN, et al.. Peptides: Basic determinants of reproductive functions. Peptides, 2015, 72: 34-43

[25] YuanL, LiuS, BaiX, et al.. Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. J Neuroinflammation, 2016, 13(1): 77

[26] HaznedarogluBZ, BeyazitY, WalkerSL, et al.. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Crit Rev Oncol Hematol, 2012, 83(1): 21-34

[27] HasgulR, UysalS, HaltasH, et al.. Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injury. Toxicol Ind Health, 2014, 30(10): 888-895

[28] BüyükB, BeyazitF. The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats. Turk J Obstet Gynecol, 2019, 16(1): 7-14

[29] YenielA, ErbasO, ErgenogluAM, et al.. Effect of oxytocin treatment on explant size, plasma and peritoneal levels of MCP-1, VEGF, TNF-α and histopathological parameters in a rat endometriosis model. Eur J Obstet Gynecol Reprod Biol, 2014, 175: 134-139

[30] SalmassiA, Acar-PerkB, SchmutzlerAG, et al.. Apoptosis resistance in endometriosis. Bioimpacts, 2011, 1(2): 129-134

[31] NieJ, LiuX, GuoSW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol, 2010, 202(4): 346.e 1-8

[32] HuangM, LiX, GuoP, et al.. The abnormal expression of oxytocin receptors in the uterine junctional zone in women with endometriosis. Reprod Biol Endocrinol, 2017, 15(1): 1

[33] GuoSW, MaoX, MaQ, et al.. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpresion of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertil Steril, 2013, 99(1): 231-240

[34] Sippel LM, Allington CE, Pietrzak RH, et al. Oxytocin and Stress-related Disorders: Neurobiological Mechanisms and Treatment Opportunities. Chronic Stress (Thousand Oaks), 2017,1

[35] Garrido-UrbaniS, DeblonN, PoherAL, et al.. Inhibitory role of oxytocin on TNF-α expression assessed in vitro and in vivo. Diabetes Metab, 2018, 44(3): 292-295

[36] AhmedMA, ElosailyGM. Role of Oxytocin in deceleration of early atherosclerotic inflammatory processes in adult male rats. Int J Clin Exp Med, 2011, 4(3): 169-178